Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03187925 · ClinicalTrials.gov registry record

Cricopharyngeal Dysfunction and Esophageal Diverticulum

A clinical trial of Zenker Diverticulum and Progressive Dysphagia, sponsored by University of Cincinnati.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT03187925 is a study of Zenker Diverticulum and Progressive Dysphagia that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03187925, a study of Zenker Diverticulum and Progressive Dysphagia, is actively recruiting participants, sponsored by University of Cincinnati.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

Patients undergoing open transcervical or endoscopic approach in which a laser or stapler is used to divide the common wall between the diverticulum and esophagus, or who are not surgical candidates but agree to follow-up.

Interventions

  • PROCEDURE open, transcervical versus rigid endoscopic treatment

Study Locations (1)

Ohio

  • UC Health Otolaryngology-Head and Neck Surgery - Cincinnati

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2017-08-15
Est. Completion 2027-06

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT03187925

The ClinicalTrials.gov registry entry for NCT03187925 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Zenker Diverticulum appearing as the primary indexed condition, and to 1 intervention - of which open, transcervical versus rigid endoscopic treatment is the first listed.

NCT03187925 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03187925 about?

NCT03187925 is a clinical study titled "Cricopharyngeal Dysfunction and Esophageal Diverticulum". Patients undergoing open transcervical or endoscopic approach in which a laser or stapler is used to divide the common wall between the diverticulum and esophagus, or who are not surgical candidates but agree to follow-up.

What is the current status of trial NCT03187925?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-08-15. Estimated completion is 2027-06.

What conditions does trial NCT03187925 study?

This clinical trial studies the following conditions: Zenker Diverticulum, Progressive Dysphagia, Pharyngoesophageal Diverticulum.

What interventions are being tested in trial NCT03187925?

The interventions under investigation include: open, transcervical versus rigid endoscopic treatment (PROCEDURE).

Who is sponsoring clinical trial NCT03187925?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03187925 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Zenker Diverticulum

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.